Home  »  Industry   »  RedHill Biopharma Ltd. (RDHL): Up ahead of its com...

RedHill Biopharma Ltd. (RDHL): Up ahead of its competition

For the readers interested in the stock health of RedHill Biopharma Ltd. (RDHL). It is currently valued at $0.18. When the transactions were called off in the previous session, Stock hit the highs of $0.175, after setting-off with the price of $0.1725. Company’s stock value dipped to $0.17 during the trading on the day. When the trading was stopped its value was $0.17.Recently in News on January 3, 2023, RedHill Announces Publication of Positive Phase 2 Study Results with Once-Daily Oral RHB-107 in Non-Hospitalized COVID-19. Positive data from a U.S. Phase 2 study of once-daily oral RHB-107 (upamostat) in symptomatic COVID-19 published in the peer-reviewed International Journal of Infectious Diseases. You can read further details here

RedHill Biopharma Ltd. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.2058 on 01/13/23, with the lowest value was $0.1501 for the same time period, recorded on 01/05/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


RedHill Biopharma Ltd. (RDHL) full year performance was -94.10%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, RedHill Biopharma Ltd. shares are logging -94.60% during the 52-week period from high price, and 40.16% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.13 and $3.27.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2302576 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the RedHill Biopharma Ltd. (RDHL) recorded performance in the market was 21.88%, having the revenues showcasing -70.20% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 15.42M, as it employees total of 201 workers.

Analysts verdict on RedHill Biopharma Ltd. (RDHL)

During the last month, 1 analysts gave the RedHill Biopharma Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4564, with a change in the price was noted -0.75. In a similar fashion, RedHill Biopharma Ltd. posted a movement of -80.89% for the period of last 100 days, recording 3,498,552 in trading volumes.

RedHill Biopharma Ltd. (RDHL): Technical Analysis

Raw Stochastic average of RedHill Biopharma Ltd. in the period of last 50 days is set at 10.26%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 63.53%. In the last 20 days, the company’s Stochastic %K was 59.40% and its Stochastic %D was recorded 58.51%.

Let’s take a glance in the erstwhile performances of RedHill Biopharma Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 21.88%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -80.32%, alongside a downfall of -94.10% for the period of the last 12 months. The shares increased approximately by -13.42% in the 7-day charts and went down by 0.59% in the period of the last 30 days. Common stock shares were lifted by -70.20% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts